Clinical Trials

NCT04813276 | ACTIVE_NOT_RECRUITING | PHASE2

336 participants

Efficacy of a Self-advocacy Serious Game Intervention

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2022-08-22
Completion:: 2026-07-31

Conditions

Self-Management
Quality of Life

Interventions

BEHAVIORAL

No Results Yet

NCT04798079 | ACTIVE_NOT_RECRUITING

2500 participants

Systems Biology of Early Atopy

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-03-18
Completion:: 2032-07-31

Conditions

Allergic Diseases
Food Allergy
Atopic Dermatitis

No Results Yet

NCT04777357 | RECRUITING | PHASE3

380 participants

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-04-28
Completion:: 2027-03-31

Conditions

Depression
Bipolar I Disorder

Interventions

DRUG

No Results Yet

NCT04759586 | ACTIVE_NOT_RECRUITING | PHASE3

244 participants

Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-10-05
Completion:: 2026-12-31

Conditions

Primary Mediastinal Large B-Cell Lymphoma

Interventions

PROCEDURE
DRUG
BIOLOGICAL
RADIATION

No Results Yet

NCT04753359 | COMPLETED | NA

180 participants

Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2022-02-01
Completion:: 2025-07-31

Conditions

Colorectal Cancer
Diet Habit

Interventions

OTHER

No Results Yet

NCT04752280 | RECRUITING | NA

326 participants

Glioblastoma Radiotherapy Using IMRT or Proton Beams

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-04-19
Completion:: 2030-09-19

Conditions

Glioblastoma

Interventions

RADIATION

No Results Yet

NCT04735016 | ACTIVE_NOT_RECRUITING

545 participants

DiamondTemp Global Registry

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-04-22
Completion:: 2031-03-31

Conditions

Arrhythmia

Interventions

DEVICE

No Results Yet

NCT04725409 | RECRUITING

100 participants

Neural Correlates of Psychiatric Disorders

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-03-31
Completion:: 2027-12-31

Conditions

Psychiatric Disorder
Memory Disorders

No Results Yet

NCT04723186 | TERMINATED | PHASE2

6 participants

MT1002 Phase II Study in ACS Patients With PCI

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-12-02
Completion:: 2023-08-31

Conditions

Acute Coronary Syndrome

Interventions

DRUG

Results Available

NCT04720157 | ACTIVE_NOT_RECRUITING | PHASE3

1140 participants

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-06-09
Completion:: 2025-01-13

Conditions

Prostatic Neoplasms

Interventions

DRUG

No Results Yet

NCT04704934 | ACTIVE_NOT_RECRUITING | PHASE3

490 participants

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-05-21
Completion:: 2026-08-31

Conditions

Gastric Cancer, Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG

No Results Yet

NCT04647253 | ACTIVE_NOT_RECRUITING | PHASE3

600 participants

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-05-11
Completion:: 2023-10-02

Conditions

In-Stent Restenosis

Interventions

DEVICE

Results Available

NCT04633252 | RECRUITING | PHASE1/PHASE2

86 participants

A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-02-23
Completion:: 2026-12-31

Conditions

Cancer Of Prostate
Prostate Neoplasms

Interventions

DRUG

No Results Yet

NCT04630652 | COMPLETED | PHASE4

24 participants

Risankizumab Long-term Remission Study

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-04-07
Completion:: 2025-05-13

Conditions

Psoriasis

Interventions

DRUG
PROCEDURE

No Results Yet

NCT04605302 | COMPLETED | NA

27 participants

Comparative Study of MCCE With/Without Tether vs Conventional Upper Endoscopy in Patients With Upper Abdominal Symptoms

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-02-10
Completion:: 2021-06-30

Conditions

Upper Gastrointestinal Symptoms

Interventions

DEVICE

Results Available

NCT04599010 | RECRUITING | NA

40 participants

Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding Difficulty

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2024-09-26
Completion:: 2027-07-31

Conditions

Body Composition
Feeding; Difficult, Newborn
Nutrition Disorder, Infant

Interventions

OTHER

No Results Yet

NCT04559217 | RECRUITING | PHASE2

20 participants

68Ga-DOTATATE Neuroblastoma Imaging Pilot

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-12-06
Completion:: 2027-12-15

Conditions

Neuroblastoma

Interventions

BIOLOGICAL

No Results Yet

NCT04529122 | COMPLETED

7864 participants

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-08-27
Completion:: 2026-04-24

Conditions

Solid Tumours

No Results Yet

NCT04439188 | ACTIVE_NOT_RECRUITING | PHASE2

35 participants

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2016-03-21
Completion:: 2020-11-10

Conditions

Advanced Lymphoma
Advanced Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm
Refractory Lymphoma
Refractory Malignant Solid Neoplasm
Refractory Multiple Myeloma

Interventions

DRUG

Results Available

NCT04439149 | ACTIVE_NOT_RECRUITING | PHASE2

24 participants

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2016-05-05
Completion:: 2020-11-10

Conditions

Advanced Lymphoma
Advanced Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm
Refractory Lymphoma
Refractory Malignant Solid Neoplasm
Refractory Multiple Myeloma

Interventions

DRUG

Results Available

NCT04414280 | ACTIVE_NOT_RECRUITING

1600 participants

The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-03-12
Completion:: 2028-04-30

Conditions

Diabetes Mellitus, Type 1

Interventions

DEVICE

No Results Yet

NCT04393701 | RECRUITING

100000 participants

A Pilot Study for Systematic Neonatal Screening for Lysosomal Storage Diseases Using Tandem Mass Spectrometry

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-03-08
Completion:: 2026-12-08

Conditions

Neonatal Screening
Lysosomal Storage Diseases

Interventions

PROCEDURE

No Results Yet

NCT04364178 | TERMINATED | PHASE1/PHASE2

8 participants

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-08-12
Completion:: 2023-02-09

Conditions

Adenovirus
Cytomegalovirus Infections
Epstein-Barr Virus

Interventions

BIOLOGICAL

Results Available

NCT04345913 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

24 participants

Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-03-01
Completion:: 2024-03-28

Conditions

Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Triple-Negative Breast Carcinoma
Unresectable Triple-Negative Breast Carcinoma

Interventions

PROCEDURE
DRUG

Results Available

NCT04320888 | ACTIVE_NOT_RECRUITING | PHASE2

1 participants

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-05-03
Completion:: 2024-09-30

Conditions

Hematopoietic and Lymphatic System Neoplasm
Recurrent Ependymoma
Recurrent Ewing Sarcoma
Recurrent Hepatoblastoma
Recurrent Histiocytic and Dendritic Cell Neoplasm
Recurrent Langerhans Cell Histiocytosis
Recurrent Lymphoma
Recurrent Malignant Germ Cell Tumor
Recurrent Malignant Glioma
Recurrent Malignant Solid Neoplasm
Recurrent Medulloblastoma
Recurrent Neuroblastoma
Recurrent Non-Hodgkin Lymphoma
Recurrent Osteosarcoma
Recurrent Peripheral Primitive Neuroectodermal Tumor
Recurrent Rhabdoid Tumor
Recurrent Rhabdomyosarcoma
Recurrent Soft Tissue Sarcoma
Recurrent WHO Grade 2 Glioma
Refractory Ependymoma
Refractory Ewing Sarcoma
Refractory Hepatoblastoma
Refractory Histiocytic and Dendritic Cell Neoplasm
Refractory Langerhans Cell Histiocytosis
Refractory Lymphoma
Refractory Malignant Germ Cell Tumor
Refractory Malignant Glioma
Refractory Malignant Solid Neoplasm
Refractory Medulloblastoma
Refractory Neuroblastoma
Refractory Non-Hodgkin Lymphoma
Refractory Osteosarcoma
Refractory Peripheral Primitive Neuroectodermal Tumor
Refractory Rhabdoid Tumor
Refractory Rhabdomyosarcoma
Refractory Soft Tissue Sarcoma
Refractory WHO Grade 2 Glioma
Wilms Tumor

Interventions

PROCEDURE
DRUG

Results Available

NCT04318717 | RECRUITING | PHASE2

20 participants

Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-05-29
Completion:: 2030-07-31

Conditions

Mucosal Melanoma of the Head and Neck

Interventions

DRUG
RADIATION

No Results Yet

NCT04312269 | RECRUITING | NA

70 participants

Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-02-25
Completion:: 2027-01-30

Conditions

Stroke

Interventions

OTHER

No Results Yet

NCT04302103 | COMPLETED | PHASE2

29 participants

A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-07-07
Completion:: 2022-01-14

Conditions

Systemic Myasthenia Gravis

Interventions

BIOLOGICAL

No Results Yet

NCT04284774 | ACTIVE_NOT_RECRUITING | PHASE2

5 participants

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-10-13
Completion:: 2024-03-31

Conditions

Malignant Solid Neoplasm
Recurrent Adrenal Gland Pheochromocytoma
Recurrent Ectomesenchymoma
Recurrent Ependymoma
Recurrent Ewing Sarcoma
Recurrent Hepatoblastoma
Recurrent Kidney Wilms Tumor
Recurrent Langerhans Cell Histiocytosis
Recurrent Malignant Germ Cell Tumor
Recurrent Malignant Glioma
Recurrent Medulloblastoma
Recurrent Melanoma
Recurrent Neuroblastoma
Recurrent Non-Hodgkin Lymphoma
Recurrent Osteosarcoma
Recurrent Peripheral Primitive Neuroectodermal Tumor
Recurrent Rhabdoid Tumor
Recurrent Rhabdoid Tumor of the Kidney
Recurrent Rhabdomyosarcoma
Recurrent Soft Tissue Sarcoma
Recurrent Thyroid Gland Carcinoma
Recurrent WHO Grade 2 Glioma
Refractory Adrenal Gland Pheochromocytoma
Refractory Ependymoma
Refractory Ewing Sarcoma
Refractory Hepatoblastoma
Refractory Langerhans Cell Histiocytosis
Refractory Malignant Germ Cell Tumor
Refractory Malignant Glioma
Refractory Medulloblastoma
Refractory Melanoma
Refractory Neuroblastoma
Refractory Non-Hodgkin Lymphoma
Refractory Osteosarcoma
Refractory Peripheral Primitive Neuroectodermal Tumor
Refractory Rhabdoid Tumor
Refractory Rhabdoid Tumor of the Kidney
Refractory Rhabdomyosarcoma
Refractory Soft Tissue Sarcoma
Refractory Thyroid Gland Carcinoma
Refractory WHO Grade 2 Glioma

Interventions

DRUG

Results Available

NCT04272281 | COMPLETED | NA

169 participants

Use of a Share Decision Making Tool in the Care of Acute Cystitis Without Risk of Complication in Primary Care

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-07-22
Completion:: 2021-12-03

Conditions

Cystitis

Interventions

PROCEDURE

No Results Yet

NCT04251806 | COMPLETED

173 participants

Sleep-disordered Breathing in Infants With Myelomeningocele

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-07-21
Completion:: 2024-04-25

Conditions

Sleep-disordered Breathing
Myelomeningocele

Interventions

DIAGNOSTIC_TEST

No Results Yet

NCT04246281 | COMPLETED | NA

230 participants

The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-06-17
Completion:: 2026-04-27

Conditions

Low Back Pain
Back Pain

Interventions

DEVICE
PROCEDURE

No Results Yet

NCT04239573 | RECRUITING

770 participants

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-06-16
Completion:: 2030-12-31

Conditions

Pancreatic Neoplasm

Interventions

PROCEDURE
OTHER

No Results Yet

NCT04230148 | COMPLETED | PHASE4

301 participants

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2022-02-11
Completion:: 2026-03-27

Conditions

Fascioliasis

Interventions

DRUG

No Results Yet

NCT04183218 | COMPLETED

24 participants

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-27
Start Date:: 2019-09-23
Completion:: 2024-01-06

Conditions

Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
Localized Esophageal Carcinoma
Localized Lung Carcinoma
Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
Stage 0 Lung Cancer AJCC v8
Stage I Lung Cancer AJCC v8
Stage IA1 Lung Cancer AJCC v8
Stage IA2 Lung Cancer AJCC v8
Stage IA3 Lung Cancer AJCC v8
Stage IB Lung Cancer AJCC v8
Stage II Lung Cancer AJCC v8
Stage IIA Lung Cancer AJCC v8
Stage IIB Lung Cancer AJCC v8
Stage III Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8
Stage IIIC Lung Cancer AJCC v8

Interventions

PROCEDURE
DEVICE
OTHER
RADIATION

Results Available

NCT04181463 | NOT_YET_RECRUITING | PHASE2

112 participants

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2026-11-05
Completion:: 2028-12-30

Conditions

Malignant Neoplasm

Interventions

DRUG
OTHER

No Results Yet

NCT04147884 | ACTIVE_NOT_RECRUITING | NA

4 participants

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2019-11-13
Completion:: 2021-12-17

Conditions

Mitral Regurgitation Functional
Mitral Valve Disease
Cardiovascular Diseases

Interventions

DEVICE

No Results Yet

NCT04126070 | ACTIVE_NOT_RECRUITING | PHASE2

47 participants

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-05-11
Completion:: 2025-07-29

Conditions

Hormone Sensitive Prostate Cancer
Prostate Adenocarcinoma
Metastasis Prostate Adenocarcinoma

Interventions

DRUG

Results Available

NCT04114669 | COMPLETED | NA

401 participants

Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2020-07-14
Completion:: 2025-05-12

Conditions

High Blood Pressure

Interventions

BEHAVIORAL

Results Available

NCT04107636 | COMPLETED | NA

45 participants

Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-27
Start Date:: 2021-08-02
Completion:: 2025-11-03

Conditions

Breast Cancer

Interventions

PROCEDURE

No Results Yet